National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Dictionary of Cancer Terms
In English   En español
Page Options
Print This Page
More NCI Dictionaries
NCI Drug Dictionary

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
In English   En español

gemtuzumab ozogamicin (gem-TOO-zeh-mab oh-zoh-GAM-ih-sin)

 A monoclonal antibody combined with a toxic substance that is used to treat certain types of acute myeloid leukemia in older patients and is being studied in the treatment of other types of cancer. Monoclonal antibodies are made in the laboratory and can locate and bind to substances in the body, including cancer cells. Gemtuzumab ozogamicin is a type of antibody-drug conjugate. Also called gemtuzumab and Mylotarg.



Previous Definitions:gemcitabine, gemcitabine hydrochloride, gemcitabine/cisplatin, gemcitabine/cisplatin regimen, gemtuzumab
Next Definitions:Gemzar, Genasense, gene, gene deletion, gene expression

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov